ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-20V14231
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2023
BUY CHAPTERS

Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2025

Code: QYRE-Auto-20V14231
Report
September 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARSGEN Therapeutics，Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc.
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Beijing Immunochina Medical Science & Technology Co Ltd

Chimeric Antigen Receptor Cell Therapy Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chimeric Antigen Receptor Cell Therapy Market

Chimeric Antigen Receptor Cell Therapy Market

The global market for Chimeric Antigen Receptor Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Chimeric Antigen Receptor (CAR) Cell Therapy is a type of immunotherapy that involves modifying a patient"s own immune cells to recognize and attack cancer cells. The process begins by collecting the patient"s T cells, a type of white blood cell, which are then genetically engineered to produce chimeric antigen receptors on their surface. These receptors enable the T cells to recognize specific proteins on the surface of cancer cells. Once the modified CAR T cells are infused back into the patient, they can target and destroy the cancer cells.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor Cell Therapy.
The Chimeric Antigen Receptor Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chimeric Antigen Receptor Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chimeric Antigen Receptor Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Chimeric Antigen Receptor Cell Therapy Market Report

Report Metric Details
Report Name Chimeric Antigen Receptor Cell Therapy Market
CAGR 5%
Segment by Type
  • MonOthersapy
  • Combination Therapy
Segment by Application
  • Acute Leukemia
  • Non-hodgkin's Lymphoma
  • Multiple Myeloma
  • Transplant Rejection
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp, Cell Medica Ltd, Cellular Biomedicine Group Inc, Celularity Inc, Celyad SA, Daiichi Sankyo Co Ltd, Fosun Pharmaceutical AG, Gilead Sciences Inc, Guangzhou Anjie Biomedical Technology Co Ltd, Hangzhou Converd Co Ltd, Hebei Senlang Biotechnology Inc Ltd, HRAIN Biotechnology Co Ltd, Juno Therapeutics Inc, Kite Pharma Inc, Nanjing Legend Biotech Co Ltd, NantKwest Inc, Nkarta Inc, Novartis AG, Ono Pharmaceutical Co Ltd, Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd, Sorrento Therapeutics Inc, Takara Bio Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chimeric Antigen Receptor Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chimeric Antigen Receptor Cell Therapy Market report?

Ans: The main players in the Chimeric Antigen Receptor Cell Therapy Market are Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp, Cell Medica Ltd, Cellular Biomedicine Group Inc, Celularity Inc, Celyad SA, Daiichi Sankyo Co Ltd, Fosun Pharmaceutical AG, Gilead Sciences Inc, Guangzhou Anjie Biomedical Technology Co Ltd, Hangzhou Converd Co Ltd, Hebei Senlang Biotechnology Inc Ltd, HRAIN Biotechnology Co Ltd, Juno Therapeutics Inc, Kite Pharma Inc, Nanjing Legend Biotech Co Ltd, NantKwest Inc, Nkarta Inc, Novartis AG, Ono Pharmaceutical Co Ltd, Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd, Sorrento Therapeutics Inc, Takara Bio Inc

What are the Application segmentation covered in the Chimeric Antigen Receptor Cell Therapy Market report?

Ans: The Applications covered in the Chimeric Antigen Receptor Cell Therapy Market report are Acute Leukemia, Non-hodgkin's Lymphoma, Multiple Myeloma, Transplant Rejection, Others

What are the Type segmentation covered in the Chimeric Antigen Receptor Cell Therapy Market report?

Ans: The Types covered in the Chimeric Antigen Receptor Cell Therapy Market report are MonOthersapy, Combination Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 MonOthersapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Acute Leukemia
1.3.3 Non-hodgkin's Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Transplant Rejection
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor Cell Therapy Market Perspective (2020-2031)
2.2 Global Chimeric Antigen Receptor Cell Therapy Growth Trends by Region
2.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chimeric Antigen Receptor Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Chimeric Antigen Receptor Cell Therapy Market Dynamics
2.3.1 Chimeric Antigen Receptor Cell Therapy Industry Trends
2.3.2 Chimeric Antigen Receptor Cell Therapy Market Drivers
2.3.3 Chimeric Antigen Receptor Cell Therapy Market Challenges
2.3.4 Chimeric Antigen Receptor Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue
3.1.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
3.4 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor Cell Therapy Revenue in 2024
3.5 Global Key Players of Chimeric Antigen Receptor Cell Therapy Head office and Area Served
3.6 Global Key Players of Chimeric Antigen Receptor Cell Therapy, Product and Application
3.7 Global Key Players of Chimeric Antigen Receptor Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chimeric Antigen Receptor Cell Therapy Market Size (2020-2031)
6.2 North America Chimeric Antigen Receptor Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025)
6.4 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2020-2031)
7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size (2020-2031)
9.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.1.5 Amgen Inc Recent Development
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Details
11.2.2 Autolus Therapeutics Plc Business Overview
11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction
11.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.2.5 Autolus Therapeutics Plc Recent Development
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Details
11.4.2 Bellicum Pharmaceuticals Inc Business Overview
11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.4.5 Bellicum Pharmaceuticals Inc Recent Development
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Details
11.5.2 Bristol-Myers Squibb Co Business Overview
11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction
11.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.5.5 Bristol-Myers Squibb Co Recent Development
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Details
11.6.2 bluebird bio Inc Business Overview
11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.6.5 bluebird bio Inc Recent Development
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Details
11.7.2 CARsgen Therapeutics Ltd Business Overview
11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.7.5 CARsgen Therapeutics Ltd Recent Development
11.8 Celgene Corp
11.8.1 Celgene Corp Company Details
11.8.2 Celgene Corp Business Overview
11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction
11.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.8.5 Celgene Corp Recent Development
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Details
11.9.2 Cell Medica Ltd Business Overview
11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.9.5 Cell Medica Ltd Recent Development
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Details
11.10.2 Cellular Biomedicine Group Inc Business Overview
11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.10.5 Cellular Biomedicine Group Inc Recent Development
11.11 Celularity Inc
11.11.1 Celularity Inc Company Details
11.11.2 Celularity Inc Business Overview
11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.11.5 Celularity Inc Recent Development
11.12 Celyad SA
11.12.1 Celyad SA Company Details
11.12.2 Celyad SA Business Overview
11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction
11.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.12.5 Celyad SA Recent Development
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Details
11.13.2 Daiichi Sankyo Co Ltd Business Overview
11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.13.5 Daiichi Sankyo Co Ltd Recent Development
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Details
11.14.2 Fosun Pharmaceutical AG Business Overview
11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction
11.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.14.5 Fosun Pharmaceutical AG Recent Development
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Details
11.15.2 Gilead Sciences Inc Business Overview
11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.15.5 Gilead Sciences Inc Recent Development
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Details
11.17.2 Hangzhou Converd Co Ltd Business Overview
11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.17.5 Hangzhou Converd Co Ltd Recent Development
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Details
11.19.2 HRAIN Biotechnology Co Ltd Business Overview
11.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.19.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.19.5 HRAIN Biotechnology Co Ltd Recent Development
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Details
11.20.2 Juno Therapeutics Inc Business Overview
11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.20.5 Juno Therapeutics Inc Recent Development
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Details
11.21.2 Kite Pharma Inc Business Overview
11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.21.5 Kite Pharma Inc Recent Development
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Details
11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.22.5 Nanjing Legend Biotech Co Ltd Recent Development
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Details
11.23.2 NantKwest Inc Business Overview
11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.23.5 NantKwest Inc Recent Development
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Details
11.24.2 Nkarta Inc Business Overview
11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.24.5 Nkarta Inc Recent Development
11.25 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction
11.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.25.5 Novartis AG Recent Development
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Details
11.26.2 Ono Pharmaceutical Co Ltd Business Overview
11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.26.5 Ono Pharmaceutical Co Ltd Recent Development
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Details
11.28.2 Sorrento Therapeutics Inc Business Overview
11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.28.5 Sorrento Therapeutics Inc Recent Development
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Details
11.29.2 Takara Bio Inc Business Overview
11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
11.29.5 Takara Bio Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARSGEN Therapeutics，Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc.
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Beijing Immunochina Medical Science & Technology Co Ltd
List of Tables
 Table 1. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of MonOthersapy
 Table 3. Key Players of Combination Therapy
 Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region (2020-2025)
 Table 8. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region (2026-2031)
 Table 10. Chimeric Antigen Receptor Cell Therapy Market Trends
 Table 11. Chimeric Antigen Receptor Cell Therapy Market Drivers
 Table 12. Chimeric Antigen Receptor Cell Therapy Market Challenges
 Table 13. Chimeric Antigen Receptor Cell Therapy Market Restraints
 Table 14. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players (2020-2025)
 Table 16. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2024)
 Table 17. Ranking of Global Top Chimeric Antigen Receptor Cell Therapy Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Chimeric Antigen Receptor Cell Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Chimeric Antigen Receptor Cell Therapy, Product and Application
 Table 21. Global Key Players of Chimeric Antigen Receptor Cell Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2020-2025)
 Table 25. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2026-2031)
 Table 27. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Application (2020-2025)
 Table 29. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Application (2026-2031)
 Table 31. North America Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Amgen Inc Company Details
 Table 47. Amgen Inc Business Overview
 Table 48. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 49. Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 50. Amgen Inc Recent Development
 Table 51. Autolus Therapeutics Plc Company Details
 Table 52. Autolus Therapeutics Plc Business Overview
 Table 53. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product
 Table 54. Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 55. Autolus Therapeutics Plc Recent Development
 Table 56. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
 Table 57. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
 Table 58. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 59. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 60. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
 Table 61. Bellicum Pharmaceuticals Inc Company Details
 Table 62. Bellicum Pharmaceuticals Inc Business Overview
 Table 63. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 64. Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 65. Bellicum Pharmaceuticals Inc Recent Development
 Table 66. Bristol-Myers Squibb Co Company Details
 Table 67. Bristol-Myers Squibb Co Business Overview
 Table 68. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product
 Table 69. Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 70. Bristol-Myers Squibb Co Recent Development
 Table 71. bluebird bio Inc Company Details
 Table 72. bluebird bio Inc Business Overview
 Table 73. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 74. bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 75. bluebird bio Inc Recent Development
 Table 76. CARsgen Therapeutics Ltd Company Details
 Table 77. CARsgen Therapeutics Ltd Business Overview
 Table 78. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 79. CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 80. CARsgen Therapeutics Ltd Recent Development
 Table 81. Celgene Corp Company Details
 Table 82. Celgene Corp Business Overview
 Table 83. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product
 Table 84. Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 85. Celgene Corp Recent Development
 Table 86. Cell Medica Ltd Company Details
 Table 87. Cell Medica Ltd Business Overview
 Table 88. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 89. Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 90. Cell Medica Ltd Recent Development
 Table 91. Cellular Biomedicine Group Inc Company Details
 Table 92. Cellular Biomedicine Group Inc Business Overview
 Table 93. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 94. Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 95. Cellular Biomedicine Group Inc Recent Development
 Table 96. Celularity Inc Company Details
 Table 97. Celularity Inc Business Overview
 Table 98. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 99. Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 100. Celularity Inc Recent Development
 Table 101. Celyad SA Company Details
 Table 102. Celyad SA Business Overview
 Table 103. Celyad SA Chimeric Antigen Receptor Cell Therapy Product
 Table 104. Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 105. Celyad SA Recent Development
 Table 106. Daiichi Sankyo Co Ltd Company Details
 Table 107. Daiichi Sankyo Co Ltd Business Overview
 Table 108. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 109. Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 110. Daiichi Sankyo Co Ltd Recent Development
 Table 111. Fosun Pharmaceutical AG Company Details
 Table 112. Fosun Pharmaceutical AG Business Overview
 Table 113. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product
 Table 114. Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 115. Fosun Pharmaceutical AG Recent Development
 Table 116. Gilead Sciences Inc Company Details
 Table 117. Gilead Sciences Inc Business Overview
 Table 118. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 119. Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 120. Gilead Sciences Inc Recent Development
 Table 121. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
 Table 122. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
 Table 123. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 124. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 125. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
 Table 126. Hangzhou Converd Co Ltd Company Details
 Table 127. Hangzhou Converd Co Ltd Business Overview
 Table 128. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 129. Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 130. Hangzhou Converd Co Ltd Recent Development
 Table 131. Hebei Senlang Biotechnology Inc Ltd Company Details
 Table 132. Hebei Senlang Biotechnology Inc Ltd Business Overview
 Table 133. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 134. Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 135. Hebei Senlang Biotechnology Inc Ltd Recent Development
 Table 136. HRAIN Biotechnology Co Ltd Company Details
 Table 137. HRAIN Biotechnology Co Ltd Business Overview
 Table 138. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 139. HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 140. HRAIN Biotechnology Co Ltd Recent Development
 Table 141. Juno Therapeutics Inc Company Details
 Table 142. Juno Therapeutics Inc Business Overview
 Table 143. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 144. Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 145. Juno Therapeutics Inc Recent Development
 Table 146. Kite Pharma Inc Company Details
 Table 147. Kite Pharma Inc Business Overview
 Table 148. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 149. Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 150. Kite Pharma Inc Recent Development
 Table 151. Nanjing Legend Biotech Co Ltd Company Details
 Table 152. Nanjing Legend Biotech Co Ltd Business Overview
 Table 153. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 154. Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 155. Nanjing Legend Biotech Co Ltd Recent Development
 Table 156. NantKwest Inc Company Details
 Table 157. NantKwest Inc Business Overview
 Table 158. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 159. NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 160. NantKwest Inc Recent Development
 Table 161. Nkarta Inc Company Details
 Table 162. Nkarta Inc Business Overview
 Table 163. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 164. Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 165. Nkarta Inc Recent Development
 Table 166. Novartis AG Company Details
 Table 167. Novartis AG Business Overview
 Table 168. Novartis AG Chimeric Antigen Receptor Cell Therapy Product
 Table 169. Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 170. Novartis AG Recent Development
 Table 171. Ono Pharmaceutical Co Ltd Company Details
 Table 172. Ono Pharmaceutical Co Ltd Business Overview
 Table 173. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 174. Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 175. Ono Pharmaceutical Co Ltd Recent Development
 Table 176. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
 Table 177. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
 Table 178. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
 Table 179. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 180. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
 Table 181. Sorrento Therapeutics Inc Company Details
 Table 182. Sorrento Therapeutics Inc Business Overview
 Table 183. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 184. Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 185. Sorrento Therapeutics Inc Recent Development
 Table 186. Takara Bio Inc Company Details
 Table 187. Takara Bio Inc Business Overview
 Table 188. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product
 Table 189. Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2020-2025) & (US$ Million)
 Table 190. Takara Bio Inc Recent Development
 Table 191. Research Programs/Design for This Report
 Table 192. Key Data Information from Secondary Sources
 Table 193. Key Data Information from Primary Sources
 Table 194. Authors List of This Report


List of Figures
 Figure 1. Chimeric Antigen Receptor Cell Therapy Picture
 Figure 2. Global Chimeric Antigen Receptor Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type: 2024 VS 2031
 Figure 4. MonOthersapy Features
 Figure 5. Combination Therapy Features
 Figure 6. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2024 VS 2031
 Figure 8. Acute Leukemia Case Studies
 Figure 9. Non-hodgkin's Lymphoma Case Studies
 Figure 10. Multiple Myeloma Case Studies
 Figure 11. Transplant Rejection Case Studies
 Figure 12. Others Case Studies
 Figure 13. Chimeric Antigen Receptor Cell Therapy Report Years Considered
 Figure 14. Global Chimeric Antigen Receptor Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Chimeric Antigen Receptor Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region: 2024 VS 2031
 Figure 17. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players in 2024
 Figure 18. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2024
 Figure 20. North America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Chimeric Antigen Receptor Cell Therapy Market Share by Country (2020-2031)
 Figure 22. United States Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Country (2020-2031)
 Figure 26. Germany Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Region (2020-2031)
 Figure 34. China Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Country (2020-2031)
 Figure 42. Mexico Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Country (2020-2031)
 Figure 46. Turkey Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Amgen Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 50. Autolus Therapeutics Plc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 51. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 52. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 53. Bristol-Myers Squibb Co Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 54. bluebird bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 55. CARsgen Therapeutics Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 56. Celgene Corp Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 57. Cell Medica Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 58. Cellular Biomedicine Group Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 59. Celularity Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 60. Celyad SA Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 61. Daiichi Sankyo Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 62. Fosun Pharmaceutical AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 63. Gilead Sciences Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 64. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 65. Hangzhou Converd Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 66. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 67. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 68. Juno Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 69. Kite Pharma Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 70. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 71. NantKwest Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 72. Nkarta Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 73. Novartis AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 74. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 75. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 76. Sorrento Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 77. Takara Bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2020-2025)
 Figure 78. Bottom-up and Top-down Approaches for This Report
 Figure 79. Data Triangulation
 Figure 80. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Chimeric Antigen Receptor CAR T Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CAR T Cellular Immunotherapy Drug Market Research Report 2024
Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024
Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
CAR T Cell Immunotherapies for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
CAR T Cell Therapy Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cellular and Gene Therapy Product Market Research Report 2025
Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Therapy CMO Market Research Report 2025
TCR Based Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global B Cell Maturation Antigen Targeted Therapy Market Research Report 2024
Global Autologous Stem Cell Based Therapies Market Research Report 2024
Global Orthopedic Cell Therapy Market Research Report 2024
Autologous Stem Cell and Non Stem Cell Based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tumor Immunotherapy Market
Diabetes Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiotherapy Device Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions